ATE — Antibe Therapeutics(Pre-Merger) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Antibe Therapeutics(Pre-Merger), fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.02	6.21	72	54.8	38.9
Net Total Accounts Receivable
Net Total Receivables	1.59	1.71	2.6	1.16	1.66
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10.6	11.5	79.1	61.4	41.5
Net Property, Plant And Equipment	0.181	0.303	0.309	0	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	14.8	13.8	81.7	89.2	70.6
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.91	7.59	3.74	4.69	2.76
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.38	10.1	31.5	32.3	30.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	7.44	3.78	50.3	56.8	40.2
Total Liabilities & Shareholders' Equity	14.8	13.8	81.7	89.2	70.6
Total Common Shares Outstanding